Eton Pharmaceuticals Raises Full-Year Outlook After Third-Quarter Revenue More Than Doubles
Eton Pharmaceuticals raised its outlook for the year after third-quarter revenue more than doubled. The stock rose 12% to $52.59 on Friday.
By Kelly CloonanShares of Eton Pharmaceuticals gained as revenue surged in the third quarter, prompting the company to raise its outlook for the year.The stock rose 12% to $52.59 on Friday. Shares have more than tripled year to date.The company swung to a third-quarter profit of $35.2 million, or…